<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Rearrangements within the T-cell receptor (TCR)delta/alpha locus were analyzed in a wide variety of lymphoid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> by eight DNA probes specific for TCR J delta, J alpha and C alpha segments </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> 11 T-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, rearrangement and/or deletion of TCR delta was detected irrespective of the stage of maturation of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The organization of TCR delta correlated with the phenotype of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>: In "prethymic" T-cell <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ALL), TCR delta was the only TCR gene to be rearranged </plain></SENT>
<SENT sid="3" pm="."><plain>More mature T cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> expressing CD4 together with CD3 showed deletion of both alleles of TCR delta, suggestive of TCR V alpha-J alpha rearrangement </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 43 B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> expressing surface immunoglobulin (sIg), including two cases of <z:e sem="disease" ids="C0279593" disease_type="Neoplastic Process" abbrv="">adult B-cell ALL</z:e>, had germline configuration of TCR delta/alpha </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, <z:hpo ids='HP_0000001'>all</z:hpo> 17 B-cell precursor ALLs (null, common, and pre-B-cell ALLs) had rearrangement and/or deletion of TCR delta/alpha </plain></SENT>
<SENT sid="6" pm="."><plain>A single case of "histiocytic" <z:hpo ids='HP_0002665'>lymphoma</z:hpo> also showed biallelic deletion of TCR delta </plain></SENT>
<SENT sid="7" pm="."><plain>Oligoclonal rearrangements of Ig and TCR genes were observed in two cases of B-cell precursor ALL and in one case of T-cell lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Patterns of such "aberrant" TCR rearrangement were similar to those observed in T-lineage <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>In particular, seven of eight cases of B-cell precursor ALL and the histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> which demonstrated biallelic TCR delta deletion, (suggestive of a V alpha-J alpha rearrangement) had clonal TCR beta rearrangement </plain></SENT>
<SENT sid="10" pm="."><plain>These data support the hypothesis that supposedly aberrant rearrangements of the TCR genes may follow the same developmental controls as found in T-cell differentiation, despite the lack of evidence for further commitment to the T-cell lineage </plain></SENT>
<SENT sid="11" pm="."><plain>TCR delta rearrangement is a useful marker of clonality of immature T-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> which may have only this gene rearranged but is not specific to the T-cell lineage </plain></SENT>
</text></document>